| Printable Version |
NADA Number: 110-048 | |
| Proprietary Name |
Valbazen® |
|---|---|
| Sponsor |
Pfizer, Inc. |
| Sponsor Address |
235 East 42d St. New York, NY 10017 USA |
| Ingredients |
Albendazole |
| Species |
Sheep, restricted during pregnancy Cattle, beef Cattle, dairy, excluding female breeding age animals Cattle, restricted during pregnancy |
| Routes of Administration |
Per Os |
| Dose Form |
Liquid (suspension) |
| Drug Form |
Liquid (suspension) |
| Dispensing Status |
OTC |
| Exclusivity |
Seven year period of marketing exclusivity granted for the use of albendazole in the treatment of nonlactating goats for adult liver fluke (Fasciola hepatica). |
| Withdrawal Time |
Cattle: 27 days before slaughter
Sheep: 7 days before slaughter
Goats: 7 days before slaughter
|
|
Dosage Amount, Indications & Limitations |
520.45a Albendazole suspension. Specifications: The product contains 11.36 percent albendazole. Conditions of use: Cattle Amount: 4.54 milligrams per pound of body weight (10 milligrams per kilogram). Administer as a single oral dose using dosing gun or dosing syringe. Indications: For removal and control of the following internal parasites of cattle: adult liver flukes (Fasciola hepatica), heads and segments of tapeworms (Moniezia benedeni, M. expansa); adult and 4th stage larvae of stomach worms (brown stomach worms including 4th stage inhibited larvae (Ostertagia ostertagi), barberpole worm (Haemonchus contortus, H. placei), small stomach worm (Trichostrongylus axei)); adult and 4th stage larvae of intestinal worms (thread-necked intestinal worm (Nematodirus spathiger, N. helvetianus), small intestinal worm (Cooperia punctata and C. oncophora)); adult stages of intestinal worms (hookworm (Bunostomum phlebotomum) bankrupt worm (Trichostrongylus colubriformis), nodular worm (Oesophagostomum radiatum)); adult and 4th stage larvae of lungworms (Dictyocaulus viviparus). Limitations: Do not use in female dairy cattle of breeding age: Do not administer to female cattle during first 45 days of pregnancy or for 45 days after removal of bulls. Specifications: The product contains 4.55 or 11.36 percent albendazole. Conditions of use: Sheep Amount: 3.4 mg/lb body weight (7.5 mg/kg) as a single oral dose using dosing gun or dosing syringe. Indications for use: For removal and control of the following internal parasites of sheep: Adult liver flukes (Fasciola hepatica, Fascioloides magna); heads and segments of common tapeworms (Moniezia expansa) and fringed tapeworm (Thysanosoma actinoides); adult and fourth stage larvae of stomach worms (brown stomach worm (Ostertagia circumcincta and Marshallagia marshalli), barberpole worm (Haemonchus contortus), small stomach worm (Trichostrongylus axei)); adult and fourth stage larvae of intestinal worms (thread-necked intestinal worm (Nematodirus spathiger and N. filicollis), Cooper's worm (Cooperia oncophora), bankrupt worm (Trichostrongylus colubriformis), nodular worm (Oesophagostomum columbianum), and large-mouth bowel worm (Chabertia ovina)); adult and larval stages of lungworms (Dictyocaulus filaria). Limitations: Do not slaughter within 7 days of last treatment. Do not administer to ewes during first 30 days of pregnancy or for 30 days after removal of rams. Conditions of use: Goats (non-lactating) Amount: 4.54 mg/lb body weight (10 mg/kg) as a single oral dose using dosing gun or dosing syringe. Indications for use: For the treatment of adult liver flukes (Fasciola hepatica) in nonlactating goats. Limitations: Do not slaughter within 7 days of last treatment. Do not administer to does during first 30 days of pregnancy or for 30 days after removal of bucks. |
| Tolerances |
Tolerances are established for residues of albendazole in uncooked edible tissues as follows: a. In cattle: the tolerance for the 2-aminosulfone metabolite (marker residue) in liver (target tissue) is 0.2 part per million and in muscle 0.05 part per million. b. In sheep: the tolerance for the 2-aminosulfone metabolite (marker residue) in liver (target tissue) is 0.25 part per million and in muscle of 0.05 part per million. |
Green Book Links

